Dixon, Thomas Anthony http://orcid.org/0000-0001-8973-8658
Muotri, Alysson R. http://orcid.org/0000-0003-0867-2875
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1R01MH128365, R01NS123642, 1R01ES033636, MH123828, MH127077, NS105969)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 11 March 2022
Revised: 5 July 2022
Accepted: 7 July 2022
First Online: 10 August 2022
Competing interests
: TAD has no competing interests to disclose, ARM is a co-founder and has equity interest in TISMOO, a company dedicated to genetic analysis and human brain organogenesis, focusing on therapeutic applications customized for autism spectrum disorders and other neurological disorders origin genetics. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its competing interests policies.